Editorial: Gynecological and gastrointestinal cancers: Recent advances in molecular diagnosis and targeted therapy

Lan Zhang; Guan Wang; Lingjuan Zhu; Wei Wei; Jin Zhang

doi:10.3389/fmolb.2023.1167337

Editorial: Gynecological and gastrointestinal cancers: Recent advances in molecular diagnosis and targeted therapy

Front Mol Biosci. 2023 Mar 3:10:1167337. doi: 10.3389/fmolb.2023.1167337. eCollection 2023.

Authors

Lan Zhang¹, Guan Wang², Lingjuan Zhu³, Wei Wei⁴, Jin Zhang⁵

Affiliations

¹ Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, China.
² State Key Laboratory of Biotherapy and Cancer Center, Nursing Key Laboratory of Sichuan Province, Innovation Center of Nursing Research, West China Hospital, and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu, China.
³ Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China.
⁴ Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA, United States.
⁵ School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, China.

No abstract available

Keywords: breast cancer; colorectal cancer; molecular mechanisms; pancreatic adenocarcinoma; prognosis; targeted therapy.

Publication types

Editorial

Grants and funding

This work was mainly supported by grants from Fundamental Research Funds for the Central Universities (Grant No. 2682022ZTPY032) and Shenzhen Science and Technology Research and Development Funds (Grant No. JCYJ20210324094612035).